Abstract

The abstract provides a concise summary of the main points discussed in the chapter on “Advanced Drug Delivery Systems in the Management of CNS Disorders.” This chapter explores diverse application of advanced drug delivery systems for the treatment of various disorders of central nervous system. It highlights the advantages of these systems, including improved drug delivery to the CNS, targeted drug delivery, optimized drug concentrations, and prolonged drug release. The chapter also provides an overview of the drug delivery systems, such as liposomes, dendrimers, nanoparticles, micelles, and their examples in CNS disorder management. Furthermore, the chapter delves into the specific applications of advanced drug delivery systems in major CNS disorders, including Alzheimer's disease, stroke, Parkinson's disease, neuropsychiatric disorders, brain tumors, and neuroinflammatory disorders. It discusses how these systems can enhance therapeutic outcomes, improve drug targeting, and reduce systemic side effects. The chapter also addresses regulatory considerations and commercialization challenges associated with advanced drug delivery systems for CNS disorders. It emphasizes the importance of meeting regulatory requirements and managing intellectual property considerations to foster innovation in the field. Additionally, market trends and opportunities for advanced drug delivery systems in CNS disorder management are explored. The concluding section highlights the future perspectives and emerging technologies in CNS drug delivery, including novel approaches for enhancing delivery of drug across the blood-brain barrier, advancements in personalized medicine, and the role of artificial intelligence and machine learning in optimizing CNS drug delivery.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.